Response to abiraterone acetate in the postchemotherapy setting in patients with castration-resistant prostate cancer whose disease progresses early on docetaxel.
Deborah Mukherji
Honoraria - Janssen Pharmaceutical
Carmel Jo Pezaro
Honoraria - Sanofi
Diletta Bianchini
No relevant relationships to disclose
Andrea Zivi
No relevant relationships to disclose
Johann Sebastian De Bono
Consultant or Advisory Role - Johnson & Johnson; Sanofi
Honoraria - Johnson & Johnson; Sanofi